Four types of tumor progression after microwave ablation of single hepatocellular carcinoma of ≤5 cm: incidence, risk factors and clinical significance

References

• Zheng R, Qu C, Zhang S, et al. Liver cancer incidence and mortality in China: temporal trends and projections to 2030. Chin J Cancer Res. 2018;30(6):571–579.
   PubMed Web of Science ®Google Scholar
• Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–1022.
   PubMed Web of Science ®Google Scholar
• Yu J, Yu XL, Han ZY, et al. Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial. Gut. 2017;66(6):1172–1173.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zheng Y, Li S, et al. Percutaneous microwave ablation of larger hepatocellular carcinoma. Clin Radiol. 2013;68(1):21–26.
   PubMed Web of Science ®Google Scholar
• Bhardwaj N, Strickland AD, Ahmad F, et al. Microwave ablation for unresectable hepatic tumours: clinical results using a novel microwave probe and generator. Eur J Surg Oncol. 2010;36(3):264–268.
   PubMed Web of Science ®Google Scholar
• Lee S, Kang TW, Song KD, et al. Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg. 2019;23:114–118.
   Google Scholar
• Kim R, Jeong WK, Kang TW, et al. Intrahepatic distant recurrence after radiofrequency ablation of hepatocellular carcinoma: relationship with portal hypertension. Acta Radiol. 2019;60(12):1609–1618.
   PubMed Web of Science ®Google Scholar
• Sparchez Z, Mocan T, Radu P, et al. Prognostic factors after percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma. Impact of incomplete ablation on recurrence and overall survival rates. J Gastrointestin Liver Dis. 2018;27(4):399–407.
   PubMed Web of Science ®Google Scholar
• Wilkinson NW, Shapiro AJ, Harvey SB, et al. Port-site recurrence reproduced in the VX-2 rabbit carcinoma model: an in vivo model comparing laparoscopic port sites and open incisions. JSLS. 2001;5:221–226.
   PubMedGoogle Scholar
• Zhai H, Liang P, Yu XL, et al. Microwave ablation in treating intrahepatic recurrence of hepatocellular carcinoma after liver transplantation: an analysis of 11 cases. Int J Hyperthermia. 2015;31(8):863–868.
   PubMed Web of Science ®Google Scholar
• Toshimori J, Nouso K, Nakamura S, et al. Local recurrence and complications after percutaneous radiofrequency ablation of hepatocellular carcinoma: a retrospective cohort study focused on tumor location. Acta Med Okayama. 2015;69(4):219–226.
   PubMed Web of Science ®Google Scholar
• Kim SM, Shin SS, Lee BC, et al. Imaging evaluation of ablative margin and index tumor immediately after radiofrequency ablation for hepatocellular carcinoma: comparison between multidetector-row CT and MR imaging. Abdom Radiol. 2017;42(10):2128–2527.
   Web of Science ®Google Scholar
• Hocquelet A, Balageas P, Frulio N, et al. Aggressive intrasegmental recurrence of periportal hepatocellular carcinoma after radiofrequency ablation: role of ablative technique and heat-sink effect. Radiology. 2015;276(3):932–933.
   PubMed Web of Science ®Google Scholar
• Sherman M, Bruix J, Porayko M, et al. Screening for hepatocellular carcinoma: the rationale for the American Association for the Study of Liver Diseases recommendations. Hepatology. 2012;56(3):793–796.
   PubMed Web of Science ®Google Scholar
• Ni JY, An C, Zhang TQ, et al. Predictive value of the albumin-bilirubin grade on long-term outcomes of CT-guided percutaneous microwave ablation in intrahepatic cholangiocarcinoma. Int J Hyperthermia. 2019;36(1):328–336.
   PubMed Web of Science ®Google Scholar
• Ahmed M. Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update: supplement to the consensus document. J Vasc Interv Radiol. 2014;25(11):1706–1708.
   PubMed Web of Science ®Google Scholar
• Song KD, Lee MW, Rhim H, et al. Aggressive intrasegmental recurrence of hepatocellular carcinoma after combined transarterial chemoembolization and radiofrequency ablation. AJR Am J Roentgenol. 2016;207(5):1122–1127.
   PubMed Web of Science ®Google Scholar
• Duszak R, Mabry MR. Clinical services in interventional radiology: results from the national medicare database and a society of interventional radiology membership survey. J Vasc Interv Radiol. 2003;14(1):75–81.
   PubMed Web of Science ®Google Scholar
• Brunello F, Carucci P, Gaia S, et al. Local tumor progression of hepatocellular carcinoma after microwave percutaneous ablation: a preliminary report. Gastroenterology Res. 2012;5(1):28–32.
   PubMedGoogle Scholar
• Yu J, Liang P, Yu XL, et al. Local tumour progression after ultrasound-guided microwave ablation of liver malignancies: risk factors analysis of 2529 tumours. Eur Radiol. 2015;25(4):1119–1126.
   PubMed Web of Science ®Google Scholar
• Tan W, Deng Q, Lin S, et al. Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and Meta-analysis. Int J Hyperthermia. 2019;36(1):264–272.
   PubMed Web of Science ®Google Scholar
• Dou JP, Yu J, Yang XH, et al. Outcomes of microwave ablation for hepatocellular carcinoma adjacent to large vessels: a propensity score analysis. Oncotarget. 2017;8(17):28758–28768.
   PubMedGoogle Scholar
• Kang TW, Lim HK, Lee MW, et al. Aggressive intrasegmental recurrence of hepatocellular carcinoma after radiofrequency ablation: risk factors and clinical significance. Radiology. 2015;276(1):274–285.
   PubMed Web of Science ®Google Scholar
• Nitta H, Allard MA, Sebagh M, et al. Prognostic value and prediction of extratumoral microvascular invasion for hepatocellular carcinoma. Ann Surg Oncol. 2019;26(8):2205–2568.
   Web of Science ®Google Scholar
• Xu G, Yang HY, Xu HF. Prediction of microvascular invasion in hepatocellular carcinoma with preoperative imaging radiomic analysis: is it ready for prime time. Hepatobiliary Pancreat Dis Int. 2019;18(3):289–290.
   PubMed Web of Science ®Google Scholar
• Ma X, Wei J, Gu D, et al. Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT. Eur Radiol. 2019;29(7):3595–3605.
   PubMed Web of Science ®Google Scholar
• Kotoh K, Nakamuta M, Morizono S, et al. A multi-step, incremental expansion method for radio frequency ablation: optimization of the procedure to prevent increases in intra-tumor pressure and to reduce the ablation time. Liver Int. 2005;25(3):542–547.
   PubMed Web of Science ®Google Scholar
• Yuan ZG, Wang ZY, Xia MY, et al. Comparison of diffusion kurtosis imaging versus diffusion weighted imaging in predicting the recurrence of early stage single nodules of hepatocellular carcinoma treated by radiofrequency ablation. Cancer Imaging. 2019;19(1):30.
   PubMed Web of Science ®Google Scholar
• Cho JY, Choi MS, Lee GS, et al. Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma. Clin Mol Hepatol. 2016;22(4):477–486.
   PubMed Web of Science ®Google Scholar
• Ishii T, Numata K, Hao Y, et al. Evaluation of hepatocellular carcinoma tumor vascularity using contrast-enhanced ultrasonography as a predictor for local recurrence following radiofrequency ablation. Eur J Radiol. 2017;89:234–241.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Akyuz M, Aksoy E, et al. Local recurrence after laparoscopic radiofrequency ablation of malignant liver tumors: results of a contemporary series. J Surg Oncol. 2017;115(7):830–834.
   PubMed Web of Science ®Google Scholar
• Xie X, Jiang C, Peng Z, et al. Local recurrence after radiofrequency ablation of hepatocellular carcinoma: treatment choice and outcome. J Gastrointest Surg. 2015;19(8):1466–1475.
   PubMed Web of Science ®Google Scholar
• Kumar A, Bal C, Srivastava DN, et al. Management of multiple intrahepatic recurrences after radiofrequency ablation of hepatocellular carcinoma with rhenium-188-HDD-lipiodol. Eur J Gastroenterol Hepatol. 2006;18(2):219–223.
   PubMed Web of Science ®Google Scholar